T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatments. Buckley M, Yeung DT, White DL, Eadie LN, et al. Leukemia 2025;39:1294-1310.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Buckley M, Yeung DT, White DL, Eadie LN, et al. T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatments. Leukemia 2025;39:1294-1310.
PMID: 40247105